A recent study published in Oncogene and led by Dr. Sun Yu's group at Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences revealed the roles and functional mechanisms of senescence-associated ...
Oct 25, 2022
0
7
Finding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Yang's lab at Baylor College of Medicine. In a study published in the Proceedings of the National Academy of Sciences, ...
Oct 17, 2022
0
117
Northwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of small-cell lung cancer, the P subtype, for which there is no current effective treatment.
Oct 5, 2022
0
323
Prostate cancer is the second most common cancer in men worldwide. It's important that men are screened for the disease to catch it early, and a study in 2017 shows that exercise and physical activity as additional therapy ...
Sep 20, 2022
0
9
Certain genetic variants found in prostate tumors of men of African descent were associated with African ancestry, according to two studies presented at the 15th AACR Conference on the Science of Cancer Health Disparities ...
Sep 19, 2022
0
5
Drugs like enzalutamide that inhibit male hormones from activating the androgen receptor have been used to treat advanced prostate cancer for more than a decade. While successful in most cases, these drugs can eventually ...
Sep 15, 2022
0
114
A Northwestern Medicine study has identified a molecular mechanism that helps regulate the progression of castration-resistant prostate cancer, according to findings published in the journal Oncogene.
Sep 5, 2022
0
995
Researchers at the Georgia Institute of Technology have found a detection method that could revolutionize cancer treatment by showing how cancers metastasize and what stage they are.
Aug 12, 2022
0
87
Artificial intelligence and machine learning are among the latest tools being used by cancer researchers to aid in detection and treatment of the disease.
Jul 5, 2022
0
81
Researchers who treated a group of post-surgery bladder cancer patients with the immunotherapy drug atezolizumab have found that patients whose blood contained circulating tumor DNA (ctDNA), responded very well to the treatment.
Jul 4, 2022
0
7
